AzTrials
AzTrials

Psychological DistressKAIROSNCT05335382

Implementation and Evaluation of Primary Care Behavioral Health in Sweden

A study testing Brief Interventions (BI) and Care As Usual (CAU) in people with Psychological Distress and Life Style Induced Illness, run by Linnaeus University at 17 sites in Sweden.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

In this multicenter study, the investigators want to compare treatment outcomes for patients with mental and behavioral health problems in traditional primary care (Care As Usual, CAU) and primary care centres that work according to the Primary Care Behavioral Health (PCBH) model. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Brief Interventions (BI) and Care As Usual (CAU)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
666 participants
Where
17 sitesSweden
Study dates
1 Jan 2022to 30 Jun 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All patients from age 18 who seek care at the PCC, who are deemed to be suitable for Behavioural Health interventions and booked to the mental health professionals at the PCC, according to screening methods and/or clinical assessments made by health care personnel at the PCC, will be included. This broad criteria reflects the naturalistic setting where decisions of clinicians, rather than highly standardized criteria, are the basis for inclusion.

Who cannot join

  • Does not speak Swedish well enough to fill out questionnaires.
  • Is in need of emergency type care, like with suicidal ideation or behaviours, ongoing psychosis or mania.

Trial locations and contacts

17 sites in 1 country.

17 sites in 1 country

Sweden17 sites
  • Närhälsan Hjällbo Vårdcentral

    Angered

  • Närhälsan Bollebygd Vårdcentral

    Bollebygd

  • Närhälsan Dalsjöfors Vårdcentral

    Dalsjöfors

  • Närhälsan Mösseberg Vårdcentral

    Falköping

  • Närhälsan Oden Vårdcentral

    Falköping

  • Närhälsan Eriksberg Vårdcentral

    Gothenburg

  • Närhälsan Gibraltargatan Vårdcentral

    Gothenburg

  • Närhälsan Majorna Vårdcentral

    Gothenburg

  • Närhälsan Sannegården Vårdcentral

    Gothenburg

  • Närhälsan Gråbo Vårdcentral

    Gråbo

  • Närhälsan Tjörn Vårdcentral

    Kållekärr

  • Närhälsan Solgärde Vårdcentral

    Kungälv

  • Närhälsan Ågårdsskogen Vårdcentral

    Lidköping

  • Närhälsan Mellerud Vårdcentral

    Mellerud

  • Närhälsan Munkedal Vårdcentral

    Munkedal

  • Närhälsan Stenungsund Vårdcentral

    Stenungsund

  • Närhälsan Källstorp Vårdcentral

    Trollhättan

Other trials in Sweden

About this study

Official title: Implementation and Evaluation of Primary Care Behavioral Health in Sweden - A Cluster Randomized Design for Superiority and Non-superiority Comparisons of Effects on Patient Reach, Availability, Costs, Sick-leave, Model Fidelity, and Patients' Everyday Function, Symptoms, and Experiences

In this multicenter study, the investigators want to compare treatment outcomes for patients with mental and behavioral health problems in traditional primary care (Care As Usual, CAU) and primary care centres that work according to the Primary Care Behavioral Health (PCBH) model. In addition to this, the investigators want to study organisation-level outcomes, such as access to care, perceived teamwork and work environment. To achieve this, primary care centres that have expressed interest in implementing PCBH will be cluster randomised between implementing directly or waiting for implementation.

Read the detailed description

The overarching goal of primary care is to offer all patients individualised and context-sensitive healthcare with high access and continuity. One of the reasons primary care struggles with this goal is that a large proportion of patients suffer from mental and behavioural health problems, alone or in combination with one or several chronic illnesses. Despite many patients needing psychosocial interventions, there is a lack of mental health professionals as well as clear pathways for these patients.

Primary Care Behavioral Health (PCBH) is an innovative way of organising primary care, where mental health professionals have more yet shorter visits, strive for same-day access, and have an active consulting role in the primary care team. To help patients achieve relevant behavioral changes, so called brief interventions are used, which are based on isolated components from psychological treatments such as Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT). Brief interventions usually stretch over 1-4 treatment sessions. Assessments within the model are generally contextual and largely avoid psychiatric diagnostics, instead focusing on the patient's situation and their associated coping strategies - whether they be positive or negative. Although PCBH is gaining in popularity, recent reviews conclude that among the evaluation trials there are very few comparative studies. As such, there is a great need for proper evaluation of a method that is already widely implemented.

Data will be collected at 17 primary care centers (PCCs) in Västra Götalandsregionen, Sweden, that have expressed an interest in implementing PCBH. The study is looking at both patient and organizational level variables. The PCCs will be randomized between implementing PCBH immediately (December 2021) or delayed with 5-9 months (implementation in late spring or early autumn of 2022). Outcome data will be collected also from the PCCs waiting for implementation, while they apply Care as Usual (CAU). Collection of patient self-ratings will start before the first implementation of PCBH to ensure functional data collection routines and possibly create a longer baseline, but the main analysis will use data from the period from when PCCs in the Early implementation arm actually have implemented PCBH to a good enough level and until PCCs in the control group start their implementation. Data from all PCCs will be continuously be collected also during the period when the delayed group implements PCBH. For individual patients, the primary end-point for the primary outcome (everyday functioning) will be 12 weeks after the first visit. Patient outcomes are also measured after 1 year.

Outcome at the organizational level will be measured in several ways, and here the primary outcome will be two measures of waiting time between identification of patient (i.e. them self-referring for mental or behavioral health issues) and the first visit: (a) actual waiting-time and (b) Outcome at the organizational level will be measured in several ways, and here the primary outcome will be two measures of waiting time between identification of patient (i.e. them self-referring for mental or behavioral health issues) and the first visit: (a) actual waiting-time for each patient identified as relevant for inclusion and (b) Third Next Available Appointment (TNAA) for the PCC as a whole, measured at the same day and time each week.

Fidelity will be measured by an expert group as well as using four questionnaires, one for each of mental health professionals, medical doctors, registered nurses and leadership. Implementation data will also be collected from these professional groups/roles at the implementing PCCs, for example with the s-NoMAD questionnaire.

During the implementation process, all psychosocial resources (all relevant psychologists, social workers, psychotherapists and so on) will be trained in the PCBH model during 3 days. The psychosocial resources are required to already be equipped with basic training in psychotherapy, for example in CBT or psychodynamic therapies. All training will be followed up with six 4-hour group supervision sessions. PCC leaders, doctors and nurses will be included in the supervision when a need to work on inter-professional issues arises and might also receive some separate, extra supervision for up till 10 h in total if necessary. In addition to this, all PCCs will go through a half-day training of all clinical personnel at the PCC, of which 2 hours is set aside with an implementation group where all professions at the PCC are represented.

The overall main research question is:

  1. Is PCBH superior to traditional primary health care in yielding the best patient outcomes regarding level of functioning (primary outcome) and symptoms, reaching the most patients, and reducing wait-times and costs? Secondary research questions include:
  2. Is (1) true also for the sub-group of complex patients with somatic/mental comorbidities and social difficulties?
  3. Is PCBH superior to traditional primary care in reducing objectively measured sick-leave? Is this, and level of functioning and symptoms, moderated by which intervention is given within PCBH? Is this true also for the sub-group of complex patients? Is this subgroup also reached by behavioral health interventions more than in traditional primary care?
  4. Does the implementation of PCBH result in lower levels of prescribed pharmacological treatment for depression, anxiety, sleep, and pain?
  5. What changes to group and organizational variables like teamwork, knowledge about and respect for other professions, clinical knowledge about behavior health and work environment satisfaction occur after the implementation of PCBH?
  6. How does the level of fidelity, acceptability and implementation quality affect patient and implementation outcomes? Do these variables moderate results in all above research questions?
  7. Which obstacles and facilitators are observed during implementation of PCBH? What factors influence fidelity and health care personnel satisfaction with PCBH?

PCBH has the potential to increase the quality and access of care for many patients with mental and behavioural health problems. This study is the first to step towards answering whether or not the effects of PCBH are large enough to merit large-scale implementation.

Being tested
Brief Interventions (BI), Care As Usual (CAU)
Medical subject headings
Stress, Psychological, Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief Interventions (BI)Behavioural

    Also called Focused CBT, Focused ACT, Focused Cognitive Behavioural Therapy, Focused Acceptance and Commitment Therapy

    'Brief Interventions' (BI) is a multitude of interventions used in patient visits within PCBH. BI start immediately at the initial consultation, which ends with a personally tailored and evidence-informed plan adjusted to the patient's context. The interventions within BI often have their foundation in CBT, ACT or Motivational Interviewing (MI), however interventions from other schools of therapy can also be used. The common theme is that they are principle-based rather than manual-based and focus on behavioural change in relation to a problem, rather than focusing on a specific diagnosis. Follow-up appointments are scheduled flexibly depending on the patient's perceived need. A BI treatment usually consists of 1-4 appointments with several weeks apart and has an open ending, where the patient easily can schedule a new appointment. Clinicians delivering brief interventions will have had 3 days of training as well as regular supervision.

  • Care As Usual (CAU)Behavioural

    Care As Usual includes the PCC's current routine care for patients with mental and behavioral problems. This can include a multitude of procedures and treatment, such as pharmacological treatment, supportive care, cognitive behavioural therapy (CBT) and psychodynamic therapy of varying lengths. Interviews with patients as well as medical journals will be used to categorise what type of care each individual patient has received.

Study groups in NCT05335382
Study groupRoleWhat they receive
Implementing PCBH directlyExperimentalPCCs randomized to this arm will immediately start the implementation of PCBH.
Receives: Behavioral: Brief Interventions (BI)
Delayed implementation of PCBHActive comparatorPCCs randomized to this arm will have a delayed start of their PCBH implementation, waiting between 5-9 months. During this time, the same patient-level and organizational-level data will be collected from these centers while they continue to use traditional primary care / Care As Usual (CAU) .
Receives: Behavioral: Care As Usual (CAU)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. WHO Disability Assessment Schedule 2.0 12-item (WHODAS-12) (4 domains)

    The eight items constituting the four domains of Life activities, Cognition, Getting along, and Participation in the 12-item version of the WHO Disability Assessment Schedule 2.0 (WHODAS-12) will be used as primary outcome, since these are condition-independent measures of Behavioral Health relevant everyday functioning. The scale ranges from 0 to 32 points. A lower score means better functioning. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, and Week 12

  2. Waiting time until first appointment

    Waiting time from the patient contacting their PCC with a behavioural health concern to being seen by a physician or psychosocial resource among patients in the study

    Measured: From documented identification/self-referral to documented first visit at PCC (up to 6 months after identification)

Secondary outcomes (27)
  1. WHO Disability Assessment Schedule 2.0 12-item (WHODAS-12) (2 domains)

    The two domains of Mobility and Self-care will be measured and the whole WHODAS will be used in some secondary analyses, but not for the primary outcome since these domains tend to form two independent factors, many patients will have initial adequate function in these domains and they are not expected to change much. The scale ranges from 0 to 48 points. A lower score means better functioning. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 12 and 1 year

  2. Third next available appointment (TNAA)

    Waiting time until next available appointment for a third hypothetical patient that calls in on a given day for every clinician at the PCC, measured on the same time every week (e. g. Mondays at 9 AM), a measure of access to and and availability of care that is independent of patients own ability to show up at an offered time.

    Measured: Measured each week from implementation to up to 2 years

  3. Patient Health Questionnaire 9-Item (PHQ-9)

    The full version of a well-validated scale for measuring depressive symptoms. PHQ-9 total score for the nine items ranges from 0 to 27. A lower score means less depressive symptoms. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 12 and 1 year

  4. Patient Health Questionnaire 2-Item (PHQ-2)

    PHQ-2 consists of two questions from the PHQ-9. This will be administered as part of the PHQ-9 on the above mentioned time points, and will replace the PHQ-9 on the mid-treatment measurements. The scale ranges from 0 to 6 points. A lower score means less depressive symptoms. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  5. Generalized Anxiety Disorder 7-item (GAD-7)

    The full version of a well-validated scale for measuring anxiety symptoms. GAD-7 total score for the seven items ranges from 0 to 21. A lower score means less anxiety symptoms. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 12 and 1 year

  6. Generalized Anxiety Disorder 2-item (GAD-2)

    GAD-2 consists of two questions from the GAD-7. This will be administered as part of the GAD-7 on the above mentioned time points, and will replace the GAD-7 on the mid-treatment measurements. The scale ranges from 0 to 6 points. A lower score means less anxiety symptoms. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  7. Social Phobia Inventory - Abbreviated version (Mini-SPIN)

    Social anxiety symptoms are measured with a very short version of a well established patient-rated scale for social phobia. The scale ranges from 0 to 12 points. A lower score means less symptoms of social anxiety. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  8. The Alcohol Use Disorders Identification Test-Concise (AUDIT-C)

    Symptoms of alcohol misuse are measured with a very short version of a well established patient-rated scale for alcohol misuse. The scale ranges from 0 to 12 points. A lower score means less symptoms of alcohol misuse. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  9. Panic Disorder Severity Scale - Self rated 2-item (PDSS-SR-MINI-2)

    Symptoms of panic attacks are measured by a very short version of a well established patient-rated scale and has been created by factor analytic item-reduction and sensitivity to change analyses from large datasets from previous trial within the research group. The scale ranges from 0 to 8 points. A lower score means less symptoms of panic disorder. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  10. Karolinska Exhaustion Disorder Scale 3-item (KEDS-3) + 2 confirming questions from the Swedish questionnaire 'självskattat utmattningssyndrom' (s-UMS) ['self-rated burnout-syndrome']

    Symptoms of stress-related exhaustion are measured with a very short version of a well established patient-rated scale and has been created by an expert group, who chose three representative questions from the original KEDS scale. To aid with diagnostics, two confirmatory questions from the Swedish s-UMS scale were added, asking for duration and presumed cause of symptoms. The scale ranges from 0 to 18 points. A lower score means less symptoms of stress-related exhaustion. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  11. Perceived Stress Scale (PSS-MINI-2) + 2 new questions

    Stress symptoms are measured by a very short version of a well established patient-rated scale and has been created by factor analytic item-reduction and sensitivity to change analyses from large datasets from previous trial within the research group. To increase face validity of the very short scale, we also added two more direct questions ("Have you been feeling stressed lately?", "Have you been feeling tense lately?"). The scale ranges from 0 to 16 points. A lower score means less stress symptoms. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  12. Insomnia Severity Index 2-item (ISI-MINI-2)

    Symptoms of sleep disorders are measured by a very short version of a well established patient-rated scale and has been created by factor analytic item-reduction and sensitivity to change analyses from large datasets from previous trial within the research group. The scale ranges from 0 to 8 points. A lower score means less sleep problems. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  13. Short Health Anxiety Inventory 3-item (SHAI-MINI-3)

    Symptoms of health anxiety are measured by a very short version of a well established patient-rated scale and has been created by factor analytic item-reduction and sensitivity to change analyses from large datasets from previous trial within the research group. The scale ranges from 0 to 9 points. A lower score means less symptoms of health anxiety. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  14. Obsessive Compulsive Disorder 3-Item (OCD-3-MINI)

    Symptoms of obsessive compulsive disorder are measured by a very short patient-rated scale and has been created by an expert group. The scale ranges from 0 to 12 points. A lower score means less obsessive/compulsive thoughts and behaviors. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  15. Pain One-item Rating

    Pain is measured on a scale from 0 to 10, where 0 is no pain and 10 is worst pain imaginable. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  16. Total symptom index

    Also, a total index for level of symptoms will be calculated from all symptom items, where different weights will be used to balance the different number of questions for different domains, for example to avoid the larger number of items related to anxiety to overshadow depression ratings. The scale ranges from 0 to 20 points. A lower score means less mental health symptoms overall. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  17. Brunnsviken Brief Quality of Life Questionnaire (BBQ)

    Quality of life will be measure be the 12-item Brunnsviken Brief Quality of life (BBQ-12), asking about importance and fulfilment of six areas (e.g. spare time quality, creative work, and friendship). The scale ranges from 0 to 96 points. A lower score means lower quality of life. As such, a higher score is a better outcome.

    Measured: Change during the period Pre, Week 12 and 1 year

  18. Outcome Rating Scale (ORS)

    The ORS is a four-item measure designed to assess areas of life functioning known to change as a result of therapeutic intervention. These include symptom distress, interpersonal well-being, social role, and overall well-being, measured by four visual analogue scales. The scale ranges from 0 to 40 points. A lower score means lower satisfaction with life areas. As such, a higher score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  19. Session Rating Scale (SRS)

    The Session Rating Scale (SRS) is a four-item visual analogue scale designed to assess key dimensions of effective therapeutic relationships. These include respect and understanding, relevance of the goals and topics, client-practitioner fit and overall alliance. The scale ranges from 0 to 40 points. A lower score means lower ratings of the therapeutic alliance. As such, a higher score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12 and 1 year

  20. Patient-rated perception and attitude toward care provider

    9-items previously used in PCBH-settings (self-report), and four items from the Client Satisfaction Questionnaire (CSQ). The scale ranges from 0 to 57 points. A lower score means less satisfaction with care. As such, a higher score is a better outcome.

    Measured: Week 12

  21. Description of Behavioral Health Plan (PCBH) as structured note by clinician in medical record

    Interview form.

    Measured: Week 12

  22. Patient recollection of plan/goal/methods, descriptions of behaviour changes made

    Interview form.

    Measured: Week 12

  23. Experienced negative/Adverse Events, where the worst and most probably care-induced event is more thoroughly described and rated on severity and perceived cause

    Interview form.

    Measured: Week 12

  24. Adverse Events-9

    9 items asking patients to detail any adverse events that occurred as a result of treatment.

    Measured: Week 12

  25. Adverse Events-3

    3 items asking patients to detail any adverse events that occurred as a result of treatment.

    Measured: Week 4, Week 8

  26. Well-being Behaviors

    11 items asking patients how often (number of days each week) they engage in behaviors related to maintaining physical and mental well-being, such as physical exercise and having adequate sleep hygiene. The first 10 items are summarized as an average where 0 is minimum and 7 is maximum. Higher scores indicate more well-being behaviors and better outcome.

    Measured: Change during the period Pre, Week 12 and 1 year

  27. Long-term WHO Disability Assessment Schedule 2.0 12-item (WHODAS-12) (4 domains)

    The same as Primary Outcome, but with a long-term time-frame. The scale ranges from 0 to 32 points. A lower score means better functioning. As such, a lower score is a better outcome.

    Measured: Change during the period Pre, Week 4, Week 8, Week 12, and 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Apr 2022
  2. Study start1 Jan 2022
  3. Primary completion4 Apr 2024
  4. Study completion30 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Primary care centers are cluster randomized between implementing PCBH directly or implementing later. Patients seeking care at each PCC are not individually randomized, but are given the form of care that is currently offered at their PCC (pre- or post-implementation).
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
666 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05335382
Sponsor's protocol ID
2020-04198-A1
Acronym
KAIROS
Status last verified
Apr 2025
First submitted
13 Mar 2022
Last updated
13 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Farnsworth von Cederwald A, Lilja JL, Hentati Isacsson N, Kaldo V. Primary Care Behavioral Health in Sweden - a protocol of a cluster randomized trial evaluating outcomes related to implementation, organization, and patients (KAIROS). BMC Health Serv Res. 2023 Oct 31;23(1):1188. doi: 10.1186/s12913-023-10180-9.

    PubMed 37907899

Questions about this trial

What is this clinical trial studying?

A study testing Brief Interventions (BI) and Care As Usual (CAU) in people with Psychological Distress and Life Style Induced Illness, run by Linnaeus University at 17 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 13 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 17 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

WHO Disability Assessment Schedule 2.0 12-item (WHODAS-12) (4 domains) (time frame: Change during the period Pre, Week 4, Week 8, and Week 12). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05335382, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in